Search Results 11-20 of 16206 for anti-TNF drugs

  1. A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... anti-tumor necrosis factor (TNF) therapy. Participation eligibility.

  2. Adalimumab-aqvh (subcutaneous route) - Mayo Clinic

    Psoriatic arthritis usually occurs with a skin condition called psoriasis. Adalimumab-aqvh may be used alone or in combination with other medicines (eg, ...

  3. Crohn's Disease Clinical Trials

    The purpose of this study is to determine whether adding low dose methotrexate to anti -TNF therapy is more effective than treatment with anti-TNF therapy alone ...

  4. Crohn's Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine whether adding low dose methotrexate to anti -TNF therapy is more effective than treatment with anti-TNF therapy alone ...

  5. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

    ... Anti-TNF Therapy. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab ...

  6. Inflammatory Bowel Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine whether adding low dose methotrexate to anti -TNF therapy is more effective than treatment with anti-TNF therapy alone ...

  7. Mayo Clinic Researchers: TNF Inhibitors May Increase Cancer Risk in the Eye

    In one of the balancing acts of medicine, the anti-inflammatory action of the drug also increases the risk for other conditions, in this case, a rare form of ...

  8. A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy - Mayo Clinic

    * Must have failed anti-TNF treatment for HS. * To be eligible for the Sub-study, participants must be naïve to biologic therapy for treatment of HS.

  9. Treatment response and management of biologics in patients with ECD - Mayo Clinic

    These include tumor necrosis factor-alpha (TNFα) inhibitors (certolizumab, infliximab, adalimumab), anti-integrin agents (vedolizumab, natalizumab), and ...

  10. Inflammatory Bowel Disease (IBD) Clinical Trials - Mayo Clinic Research

    The purpose of this study is to compare the efficacy of treatment with ustekinumab or adalimumab in biologic naive participants with moderately-to-severely ...